| Alvesco (ciclesonide) / Covis Pharma, Teijin, Korea University Medical Center |
NCT00546520: Effect of Inhaled Ciclesonide in Adult Patients With Asthma (BY9010/M1-125) |
|
|
| Completed | 3 | 21 | Europe | Ciclesonide | AstraZeneca | Asthma | 06/02 | 06/02 | | |
NCT00163410: Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (4 to 15 y) (BY9010/M1-205) |
|
|
| Completed | 3 | 500 | RoW | Ciclesonide | AstraZeneca | Asthma | 12/04 | 12/04 | | |
NCT00163384: Effectiveness of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-136) |
|
|
| Completed | 3 | 240 | RoW | Ciclesonide | AstraZeneca | Asthma | 05/05 | 05/05 | | |
NCT00254956: Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent Asthma |
|
|
| Completed | 3 | 1568 | Europe | ciclesonide (XRP1526) | Sanofi, Takeda | Respiratory Tract Diseases, Respiratory Hypersensitivity, Asthma | 06/05 | 06/05 | | |
NCT00163397: Efficacy of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-137) |
|
|
| Completed | 3 | 120 | RoW | Ciclesonide | AstraZeneca | Asthma | 07/05 | 07/05 | | |
NCT00163358: Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132) |
|
|
| Completed | 3 | 630 | Canada, Europe, RoW | Ciclesonide | AstraZeneca | Asthma | 10/05 | 10/05 | | |
NCT00163462 / 2004-000825-31: Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (6 to 11 y) (BY9010/M1-206) |
|
|
| Completed | 3 | 750 | Europe, RoW | Ciclesonide | AstraZeneca | Asthma | 11/05 | 11/05 | | |
NCT00163319: Efficacy of Ciclesonide and Fluticasone Propionate in Adult Patients With Moderate and Severe Persistent Asthma (18 to 75 y) (BY9010/IT-101) |
|
|
| Completed | 3 | 500 | Europe | Ciclesonide | AstraZeneca | Asthma | | 11/05 | | |
NCT00163371 / 2005-001386-34: Effects of Inhaled Ciclesonide Versus Fluticasone Propionate Versus Placebo on Lower Leg Growth in Prepubertal Children With Mild Persistent Asthma (6 to 12 y) (BY9010/M1-208) |
|
|
| Completed | 3 | 28 | Europe | Ciclesonide | AstraZeneca | Asthma | 12/05 | 12/05 | | |
NCT00163423 / 2004-001072-39: Efficacy of Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (12 to 75 y) (BY9010/M1-142) |
|
|
| Completed | 3 | 480 | Canada, Europe, RoW | Ciclesonide | AstraZeneca | Asthma | 01/06 | 01/06 | | |
NCT00163436 / 2005-002163-84: Efficacy and Safety of Ciclesonide Administered With or Without Different Spacers in Patients With Asthma (12 to 75 y) (BY9010/M1-145) |
|
|
| Completed | 3 | 450 | Canada, Europe, RoW | Ciclesonide | AstraZeneca | Asthma | 01/06 | 01/06 | | |
NCT00174733: Efficacy of Ciclesonide Versus Placebo Administered Either as Once Daily or Twice Daily in Patients Treated Previously With an Inhaled Corticosteroid |
|
|
| Completed | 3 | 456 | US | Ciclesonide (XRP1526) | Sanofi | Asthma | 02/06 | 02/06 | | |
NCT00163345: Efficacy of Ciclesonide on Small Airways in Patients With Stable Asthma (18 to 60 y) (BY9010/M1-131) |
|
|
| Completed | 3 | 20 | Europe | Ciclesonide | AstraZeneca | Asthma | 05/06 | 05/06 | | |
| Completed | 3 | 1000 | Europe, RoW | Ciclesonide, Placebo | AstraZeneca | Asthma | 11/06 | 05/07 | | |
NCT00174720: Efficacy of Ciclesonide vs Placebo Administered as Once Daily or Twice Daily in Patients Not Treated With Inhaled Corticosteroid. |
|
|
| Completed | 3 | 708 | US, Europe, RoW | Ciclesonide (XRP1526) | Sanofi | Asthma | 02/07 | 02/07 | | |
NCT00305461: Effect of Ciclesonide on Quality of Life in Patients With Moderate Persistent Asthma (21 to 65 y) (BY9010/AR-101) |
|
|
| Completed | 3 | 101 | RoW | Ciclesonide | AstraZeneca | Asthma | 03/07 | 02/08 | | |
| Completed | 3 | 1080 | Europe, RoW | Ciclesonide, Placebo, Salbutamol | AstraZeneca, Nycomed GmbH | Asthma | 08/07 | 08/08 | | |
| Completed | 3 | 528 | US, Europe, RoW | Ciclesonide, Placebo | AstraZeneca | Asthma | 02/08 | 02/08 | | |
NCT00306163: Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101) |
|
|
| Completed | 3 | 37 | Europe | Ciclesonide, Fluticasone | AstraZeneca | Asthma | 08/08 | 09/08 | | |
| Completed | 3 | 240 | Canada, Europe, RoW | Ciclesonide, Alvesco®, Placebo | AstraZeneca | Asthma | 06/09 | 04/10 | | |
VIDA, NCT01248065: Study of the Effect of Vitamin D as an Add-on Therapy to Corticosteroids in Asthma |
|
|
| Completed | 3 | 408 | US | Vitamin D3, Ciclesonide, Alvesco® | Milton S. Hershey Medical Center, National Heart, Lung, and Blood Institute (NHLBI) | Asthma | 01/14 | 01/14 | | |
| Completed | 3 | 520 | Europe, RoW | Ciclesonide | AstraZeneca | Bronchial Asthma | 08/14 | 08/14 | | |
NCT00163332: Effect of Inhaled Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (18 to 65 y) (BY9010/M1-129) |
|
|
| Completed | 3 | 30 | Europe | Ciclesonide | AstraZeneca | Asthma | | | | |
